Skip to content

Insider · CIK 0001207789

SCHOEMAKER KATHLEEN K

Reports to the SEC for 31 companies · PRINCETON, NJ

Transactions

50

Companies

31

Filings

3

CIK

0001207789

Forms 4 and 5

Insider transactions

50 trades
DateCompanyValue
2014-03-19CADENCE PHARMACEUTICALS INCD Disposition to Issuer−$41.6M
2014-03-19CADENCE PHARMACEUTICALS INCD Disposition to Issuer−$710K
2014-03-19CADENCE PHARMACEUTICALS INCD Disposition to Issuer−$102M
2014-03-19CADENCE PHARMACEUTICALS INCD Disposition to Issuer−$1.1M
2014-03-19CADENCE PHARMACEUTICALS INCD Disposition to Issuer−$385K
2014-03-17Achaogen, Inc.C Conversion—
2014-03-17Achaogen, Inc.C Conversion—
2014-03-17Achaogen, Inc.Series B Preferred StockC Conversion—
2014-03-17Achaogen, Inc.Series C Preferred StockC Conversion—
2014-03-17Achaogen, Inc.Series D Preferred StockC Conversion—
2014-03-17Achaogen, Inc.Series B Preferred StockC Conversion—
2014-03-17Achaogen, Inc.Series C Preferred StockC Conversion—
2014-03-17Achaogen, Inc.Series D Preferred StockC Conversion—
2014-02-04Dicerna Pharmaceuticals IncC Conversion—
2014-02-04Dicerna Pharmaceuticals IncC Conversion—
2014-02-04Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion—
2014-02-04Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion—
2014-02-04Dicerna Pharmaceuticals IncWarrantC Conversion—
2014-02-04Dicerna Pharmaceuticals IncWarrantC Conversion—
2014-02-04Dicerna Pharmaceuticals IncSeries B Preferred StockC Conversion—
2014-02-04Dicerna Pharmaceuticals IncSeries C Preferred StockC Conversion—
2014-02-04Dicerna Pharmaceuticals IncWarrantC Conversion—
2014-02-04Dicerna Pharmaceuticals IncWarrantC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INCC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INCC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Series B Preferred StockC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Series C Preferred StockC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Series D Preferred StockC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Series D Preferred StockJ Other—
2013-11-19TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Common StockJ Other—
2013-11-19TNDMTANDEM DIABETES CARE INC · Series B Preferred StockC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Series C Preferred StockC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Series D Preferred StockC Conversion—
2013-11-19TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Series D Preferred StockJ Other—
2013-11-19TNDMTANDEM DIABETES CARE INC · Warrant to Purchase Common StockJ Other—
2013-11-04VCYTVERACYTE, INC.C Conversion—
2013-11-04VCYTVERACYTE, INC.C Conversion—
2013-11-04VCYTVERACYTE, INC. · Series B Preferred StockC Conversion—
2013-11-04VCYTVERACYTE, INC. · Series B Preferred StockC Conversion—
2013-11-04VCYTVERACYTE, INC. · Series C Preferred StockC Conversion—
2013-11-04VCYTVERACYTE, INC. · Series C Preferred StockC Conversion—
2013-09-30EVOKEvoke Pharma IncC Conversion—
2013-09-30EVOKEvoke Pharma IncC Conversion—
2013-09-30EVOKEvoke Pharma Inc · Series A Preferred StockC Conversion—
2013-09-30EVOKEvoke Pharma Inc · Series A Preferred StockC Conversion—
2013-08-27Tobira Therapeutics, Inc.C Conversion—
2013-08-27Tobira Therapeutics, Inc.C Conversion—
2013-08-27Tobira Therapeutics, Inc.C Conversion—
2013-08-27Tobira Therapeutics, Inc.C Conversion—
2013-08-27Tobira Therapeutics, Inc.P Purchase+$3M